Join Us on a Journey: Phio Pharmaceuticals Takes Part in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Welcome to the Future of Cancer Treatment Join us for an Exclusive Presentation and Live Q&A Session Thursday, November 7 at 12:00 pm EST Phio Pharmaceuticals Corp., a cutting-edge clinical-stage biotechnology company, is revolutionizing the fight against cancer with its groundbreaking INTASYL® siRNA gene silencing technology. By enhancing the body’s immune cells to better target…